Population Pharmacokinetic Modeling and Simulation of TQ-B3101 to Inform Dosing in Pediatric Patients With Solid Tumors

Population Pharmacokinetic Modeling and Simulation of TQ-B3101 to Inform Dosing in Pediatric Patients With Solid Tumors

Background: TQ-B3101 is a novel kinase inhibitor currently in development for the treatment of advanced malignant solid tumor and relapsed or refractory ALK-positive anaplastic large cell lymphoma.Methods: A population pharmacokinetic model was developed using data collected from a Phase 1 study and...

Full description

Bibliographic Details
Main Authors:	Fen Yang, Huali Wu, Yunhai Bo, Ye Lu, Hong Pan, Su Li, Qin Lu, Simin Xie, Harry Liao, Bing Wang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-01-01
Series:	Frontiers in Pharmacology
Subjects:	TQ-B3101 pediatric pharmacokinetic model solid tumor
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2021.782518/full

Similar Items

Population pharmacokinetic analysis of TQ-B3203 following intravenous administration of TQ-B3203 liposome injection in Chinese patients with advanced solid tumors
by: Xiaoqing Li, et al.
Published: (2023-01-01)

Simultaneous Determination of Four Tanshinones by UPLC-TQ/MS and Their Pharmacokinetic Application after Administration of Single Ethanol Extract of Danshen Combined with Water Extract in Normal and Adenine-Induced Chronic Renal Failure Rats
by: Hong-Die Cai, et al.
Published: (2016-11-01)

First-in-Human, Double-Blind, Randomized, Placebo-Controlled Trial of TQ-F3083, a New Dipeptidyl Peptidase-4 Inhibitor, in Healthy Chinese Adults
by: Jingrui Liu, et al.
Published: (2021-07-01)

Development of a UPLC-TQ/MS Approach for the Determination of Eleven Bioactive Components in Haizao Yuhu Decoction Plus-Minus Haizao and Gancao Drug Combination after Oral Administration in a Rat Model of Hypothyroidism
by: Yingchang Ma, et al.
Published: (2016-12-01)

Safety, Stability, and Therapeutic Efficacy of Long-Circulating TQ-Incorporated Liposomes: Implication in the Treatment of Lung Cancer
by: Arif Khan, et al.
Published: (2022-01-01)

Validation of the Italian Tinnitus Questionnaire Short Form (TQ 12-I) as a Brief Test for the Assessment of Tinnitus-Related Distress: Results of a Cross-Sectional Multicenter-Study
by: Roland Moschen, et al.
Published: (2018-01-01)

Development of a pediatric physiologically-based pharmacokinetic model to support recommended dosing of atezolizumab in children with solid tumors
by: Weize Huang, et al.
Published: (2022-09-01)

Antifungal Activity of Bacillus coagulans TQ33, Isolated from Skimmed Milk Powder, against Botrytis cinerea
by: Rui Feng Xiao, et al.
Published: (2013-01-01)

The Complex Trauma Questionnaire (ComplexTQ):Development and preliminary psychometric properties of an instrument for measuring early relational trauma
by: Carola eMaggiora Vergano, et al.
Published: (2015-09-01)

Anemarrhena asphodeloides Non-Steroidal Saponin Components Alter the Pharmacokinetic Profile of Its Steroidal Saponins in Rat
by: Zhishu Tang, et al.
Published: (2015-06-01)

Tacrolimus Pharmacokinetic and Pharmacogenomic Differences between Adults and Pediatric Solid Organ Transplant Recipients
by: Amy Lu, et al.
Published: (2010-09-01)

Chemical Profile Determination and Quantitative Analysis of Components in Oryeong-san Using UHPLC-Q-Orbitrap-MS and UPLC-TQ-MS/MS
by: Seol Jang, et al.
Published: (2023-04-01)

TQ-6, a Novel Ruthenium Derivative Compound, Possesses Potent Free Radical Scavenging Activity in Macrophages and Rats
by: Kao-Wei Hung, et al.
Published: (2021-01-01)

Physiologically based pharmacokinetic modeling of daptomycin dose optimization in pediatric patients with renal impairment
by: Lingling Ye, et al.
Published: (2022-08-01)

Dose recommendations for intravenous colistin in pediatric patients from a prospective, multicenter, population pharmacokinetic study
by: Noppadol Wacharachaisurapol, et al.
Published: (2021-08-01)

Optimizing gentamicin dosing in different pediatric age groups using population pharmacokinetics and Monte Carlo simulation
by: Ragia H. Ghoneim, et al.
Published: (2021-08-01)

Single-Dose Pharmacokinetics and Metabolism of the Oral Decongestant Phenylephrine HCl in Children and Adolescents
by: Cathy K. Gelotte, et al.
Published: (2022-12-01)

Qualitative Profiling and Quantitative Analysis of Major Constituents in Jinmu-tang by UHPLC-Q-Orbitrap-MS and UPLC-TQ-MS/MS
by: Seol Jang, et al.
Published: (2022-11-01)

Persistent Pharmacokinetic Challenges to Pediatric Drug Development
by: Daniel eSage, et al.
Published: (2014-08-01)

Systematic Review of Pharmacogenetic Factors That Influence High-Dose Methotrexate Pharmacokinetics in Pediatric Malignancies
by: Zachary L. Taylor, et al.
Published: (2021-06-01)

Population pharmacokinetics of docetaxel in patients with solid tumors
by: XI Xin, et al.
Published: (2022-11-01)

Study of the Phenolic Compound Profile of <i>Arbutus unedo</i> L. Fruits at Different Ripening Stages by HPLC-TQ-MS/MS
by: Sergio Izcara, et al.
Published: (2021-12-01)

Pharmacokinetics of solifenacin in pediatric populations with overactive bladder or neurogenic detrusor overactivity
by: Stacey Tannenbaum, et al.
Published: (2020-12-01)

Assessment of Initial Vancomycin Dosing in Pediatric Oncology Patients
by: Hillary Orr, et al.
Published: (2017-08-01)

Individual ingredients of NP-101 (Thymoquinone formula) inhibit SARS-CoV-2 pseudovirus infection
by: Abdelrahim Maen, et al.
Published: (2024-02-01)

Pharmacokinetics and therapeutic target attainment of vancomycin in pediatric post-liver transplant patients
by: Ronaldo Morales Junior, et al.
Published: (2023-11-01)

Population Pharmacokinetics of High-Dose Methotrexate in Chinese Pediatric Patients With Acute Lymphoblastic Leukemia
by: Xuan Gao, et al.
Published: (2021-07-01)

Coping in Chronic Tinnitus Patients
by: Sebastiaan M. Meijers, et al.
Published: (2020-11-01)

Pharmacokinetics of Vancomycin in Pediatric Patients Receiving Intermittent Hemodialysis or Hemodiafiltration
by: Erin Chung, et al.
Published: (2021-04-01)

Knowledge Gaps in the Pharmacokinetics of Therapeutic Proteins in Pediatric Patients
by: Bernd Meibohm
Published: (2022-02-01)

Modeling Approach to Optimizing Dose Regimen of Vancomycin for Chinese Pediatric Patients with Gram-Positive Bacterial Infections
by: Kai Shen, et al.
Published: (2021-04-01)

Efficacy, safety and pharmacokinetics of Unecritinib (TQ-B3101) for patients with ROS1 positive advanced non-small cell lung cancer: a Phase I/II Trial
by: Shun Lu, et al.
Published: (2023-06-01)

Using real-world data to inform dosing strategies of rituximab for pediatric patients with frequent-relapsing or steroid-dependent nephrotic syndrome: a prospective pharmacokinetic-pharmacodynamic study
by: Yewei Chen, et al.
Published: (2024-01-01)

Pharmacokinetics of rivaroxaban in children using physiologically based and population pharmacokinetic modelling: an EINSTEIN-Jr phase I study
by: Stefan Willmann, et al.
Published: (2018-12-01)

Pharmacokinetics of Intranasally Administered Dexmedetomidine in Chinese Children
by: Cheng-Yu Wang, et al.
Published: (2019-07-01)

A physiologically based pharmacokinetic model of cefepime to predict its pharmacokinetics in healthy, pediatric and disease populations
by: Muhammad Talha Zahid, et al.
Published: (2023-08-01)

Application of Modelling and Simulation Approaches to Predict Pharmacokinetics of Therapeutic Monoclonal Antibodies in Pediatric Population
by: Andrew Lim, et al.
Published: (2023-05-01)

A Comprehensive Physiologically Based Pharmacokinetic Model of Nadolol in Adults with Renal Disease and Pediatrics with Supraventricular Tachycardia
by: Samia Kalsoom, et al.
Published: (2024-02-01)

Prediction of pediatric dose of tirzepatide from the reference adult dose using physiologically based pharmacokinetic modelling
by: Ruifang Guan, et al.
Published: (2023-11-01)

External Evaluation of Risperidone Population Pharmacokinetic Models Using Opportunistic Pediatric Data
by: Eleni Karatza, et al.
Published: (2022-03-01)